Mar. 16 at 2:43 PM
Magdalena Biosciences, the joint venture between Jaguar Health (
$JAGX) and Filament Health (
$FLHLF), has started a one‑month mouse study in Alberta testing a whole‑leaf coca extract as an appetite suppressant aimed at helping people maintain weight loss after GLP‑1 obesity drugs, marking its first obesity‑focused program on top of its broader plant‑based CNS pipeline.
https://prismmarketview.com/magdalena-biosciences-the-jaguar-health-filament-health-jv-has-begun-preclinical-tests-of-coca-based-appetite-suppressants/